Sept 8 (Reuters) - Vanc Pharmaceuticals Inc VANC.V
* Vanc pharmaceuticals receives health canada class-iii approval for ferrous fumarate products
* Vanc pharmaceuticals inc - has received health canada class-iii approval of ferrous fumarate tablets and capsules for use in iron deficiency anemia
* Vanc pharmaceuticals inc - that it will not be proceeding with 2nd tranche closing of non-brokered private placement announced july 20, 2017
* Vanc pharmaceuticals inc - plans to secure additional financing in due course